Stock screenerAll disclosures →
EDGAR →
XENE
Conviction 52HealthcareScan · Thu, Jun 25, 2026Three outside up
XENE$56.76+2.11%
ResistanceSupportVol 14Insider sell2
Vol MA14 1.37M
Mar 26Apr 14May 1May 19Jun 8Jun 25
Price56.76
Change+2.11%
Gap+0.22%
Rel volume0.99×
Avg volume1.47M
Avg $ vol78.32M
SMA 2053.26
SMA 5054.83
SMA 20046.78
Price vs 50+3.51%
Price vs 200+21.31%
MA stackbullish
50/200 cross—
Supertrenddown · 56.85
RSI (14)63
MACD hist0.56
MACD crossbull · 5d
Stoch %K / %D94 / 85
ADX (14)16
+DI / −DI25 / 12
RSI divergence—
MACD divergence—
ATR %+3.06%
ADR %3.27%
52w high62.76
52w low30.30
From 52w high-9.57%
Above 52w low+87.31%
New 52w highNo
SqueezeOff
Bollinger width10.98%
%B1.10
Donchian pos93.90%
Donchian high57.14
Donchian low50.91
AVWAP (52w high)55.72
vs AVWAP high+1.86%
AVWAP (52w low)47.65
vs AVWAP low+19.11%
OBV trendFlat
Chaikin MF (20)-0.14
Today vs 20d0.99×
Avg vol (14d)1.37M
Avg vol (20d)1.47M
Avg $ vol (20d)78.32M
Market cap5.49B
RS 3m (vs SPY)-8.14%
RS 6m (vs SPY)+18.30%
RS line new highNo
Trend template7/8
Technical rank82.9
1 week+6.68%
1 month+5.14%
3 months+2.13%
6 months+23.17%
1 year+76.42%
YTD+27.57%
P/E-15.86
P/B4.10
P/S—
P/FCF-19.60
EPS-4.36
Div yield—
ROE-25.86%
ROA-24.94%
Debt/Eq0.01
Current27.79
EV/EBITDA-13.31
Gross margin—
Net margin—
Rev growth—
EPS growth-47.62%
Price target75.77
Target upside33.50%
Analyst ratingBuy
Institutional105.24%
Ent. value4.96B
Revenue264K
Net income-102.3M
Gross profit—
Free cash flow-279.92M
IndustryPHARMACEUTICAL PREPARATIONS
ExchangeNasdaq
Shares out96.67M
Employees370
ListedWed, Nov 5, 2014
Free float68.69M
Float %88.9%
Short interest4.04M
Days to cover2.9d
Short volume62.4%
Squeeze score41 / 100
Next earnings—
EPS forecast—
Last EPS vs est−$1.17 vs −$1.17
Last surprise0.0% beat
Setup gradeC
Conviction52 / 100
Pattern quality—
Tech rank82.9 / 100
Group rank50 / 100
Status lane—
Setup direction—
Pattern family
Resistance—
Support—
Days since event—
Candle confirmThree outside up
News sentiment—
Financials as of Tue, Mar 31, 2026 · quarterly.
Congress activity
Disclosed STOCK Act trades in XENE
No recent disclosed trades by Congress in XENE. STOCK Act filings can lag the trade by up to 45 days.
Insider activity
SEC Form 4 transactions in XENE · 7 buys · 2 sells
| Insider | Side | Shares | Value | Traded | Filed |
|---|---|---|---|---|---|
PATOU GARY Director · Common Shares · 2026-06-05 | Other | — | — | 2026-06-05 | 2026-06-08 |
Cannon Gillian Director · Common Shares · 2026-06-05 | Sell | 1.19K | $63K | 2026-06-05 | 2026-06-08 |
PATOU GARY Director · Common Shares · 2026-06-05 | Sell | 1.32K | $70K | 2026-06-05 | 2026-06-08 |
GAROFALO ELIZABETH A. Director · Share Option (Right to Buy) · 2026-06-03 | Grant | 10.51K | $0 | 2026-06-03 | 2026-06-03 |
Svoronos Dawn Director · Restricted Share Units · 2026-06-03 | Grant | 1.59K | $0 | 2026-06-03 | 2026-06-03 |
PATOU GARY Director · Share Option (Right to Buy) · 2026-06-03 | Grant | 10.51K | $0 | 2026-06-03 | 2026-06-03 |
Cannon Gillian Director · Share Option (Right to Buy) · 2026-06-03 | Grant | 10.51K | $0 | 2026-06-03 | 2026-06-03 |
Cannon Gillian Director · Restricted Share Units · 2026-06-03 | Grant | 1.59K | $0 | 2026-06-03 | 2026-06-03 |
GANNON STEVEN Director · Restricted Share Units · 2026-06-03 | Grant | 1.59K | $0 | 2026-06-03 | 2026-06-03 |
Machado Patrick Director · Share Option (Right to Buy) · 2026-06-03 | Grant | 10.51K | $0 | 2026-06-03 | 2026-06-03 |
SEC filings
EDGAR filings in XENE · 3 recent
Get daily signals & real-time alerts.
StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 7 days, cancel in one click.
Start free — 7-day full access →Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.